Qurient Co., Ltd. (KOSDAQ:115180)
17,970
+180 (1.01%)
At close: Jul 27, 2026
Qurient Market Cap
Qurient has a market cap or net worth of 688.04 billion as of July 28, 2026. Its market cap has increased by 70.54% in one year.
Market Cap
688.04B
Enterprise Value
662.74B
Revenue
7.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,970.00
ChartMarket Cap Chart
Since February 29, 2016, Qurient's market cap has increased from 281.86B to 688.04B, an increase of 144.11%. That is a compound annual growth rate of 8.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 730.74B | -38.35% |
| Dec 30, 2025 | 1.19T | 674.51% |
| Dec 30, 2024 | 153.05B | 69.38% |
| Dec 28, 2023 | 90.36B | -24.77% |
| Dec 29, 2022 | 120.11B | -63.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 1.36T |
| JS Link | 1.14T |
| Rznomics | 744.07B |
| ROKIT Healthcare | 698.05B |
| AprilBio | 580.66B |
| Inventage Lab | 391.02B |
| Curocell | 358.57B |
| IntoCell | 296.68B |